Cafepharma Today

April 17 2024 - Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Roche touts near-complete suppression of multiple sclerosis relapse for injectable Ocrevus
Lilly eyes Zepbound label expansion after clearing phase III sleep apnea study
3 patent expirations in 2024 and how companies are pivoting
Abbott beats Wall Street expectations with med device sales, raises outlook
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis touts surrogate endpoint win, nabs priority review for Fabhalta in IgAN
Fierce Pharma
Monday, April 15, 2024 - 9:32pm
tags:
Novartis, Fabhalta, IgAN, priority review, FDA
Drugmakers' low U.S. taxes belie their high sales
NPR
Monday, April 15, 2024 - 9:31pm
tags:
taxes, pharma industry
Eli Lilly's nationwide insulin pricing settlement called off
Reuters
Monday, April 15, 2024 - 9:28pm
tags:
Eli Lilly, insulin, diabetes, drug pricing, legal
14 Deaths Connected to Latest Abbott HeartMate Recall
Medical Devices and Diagnostics Industry
Monday, April 15, 2024 - 9:27pm
tags:
Medtech, Abbott Labs, HeartMate, patient deaths, device recalls
5 Promising MASH Therapies That Could Follow Madrigal’s Rezdiffra
BioSpace
Monday, April 15, 2024 - 11:24am
tags:
MASH, NASH, Madrigal Pharmaceuticals, Rezdiffra, Ionis Pharmaceuticals, ION224, Altimmune, pemvidutid, 89Bio, pegozafermin, Viking Therapeutics, VK2809, Aligos Therapeutics, ALG-055009
MaaT Pharma’s GvHD drug boasts 18-month overall survival improvement
Clinical Trials Arena
Monday, April 15, 2024 - 11:20am
tags:
MaaT Pharma, MaaT013, graft vs host disease, clinical trials
Covid vaccines not linked to fatal heart problems in young people, CDC finds
NBC News
Monday, April 15, 2024 - 11:18am
tags:
CDC, vaccines, COVID-19, Pfizer, Moderna Therapeutics
Q&A: Legend Biotech CEO on whether Carvykti can meet expectations
Medical Marketing and Media
Monday, April 15, 2024 - 11:16am
tags:
Legend Biotech, Carvykti, mutliple myeloma, JNJ
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
Biopharma Reporter
Monday, April 15, 2024 - 11:11am
tags:
Pfizer, Velsipity, UK, ulcerative colitis
4 Investigational Weight Loss Drugs That Could Change the Market
BioSpace
Monday, April 15, 2024 - 11:09am
tags:
weight loss, Novo Nordisk, CagriSema, Eli Lilly, orforglipro, Viking Therapeutics, VK-2735, Inversago Pharma, INV-202
Roche’s Columvi offers survival benefit in Phase III DLBCL trial
Clinical Trials Arena
Monday, April 15, 2024 - 11:07am
tags:
Roche, clinical trials, Columvi, DLBCL
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment
BioSpace
Monday, April 15, 2024 - 11:06am
tags:
AbbVie, clinical trials, migraines, Qulipta
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond
Fierce Biotech
Monday, April 15, 2024 - 11:04am
tags:
Regeneron, funding, venture capital, biotech
A two-decade bet on Seagen pays off
Stat
Monday, April 15, 2024 - 11:03am
tags:
Pfizer, Seagen, M&A
Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits
Fierce Biotech
Monday, April 15, 2024 - 11:00am
tags:
Neumora Therapeutics, schizophrenia, FDA, clinical trials, NMRA-266
Activist hedge fund seeks big shake-up at Novavax
Pharmaphorum
Monday, April 15, 2024 - 10:59am
tags:
Novavax, Shah Capital, activist investors
Rinvoq reclaims top Rx, OTC pharma brand crown
Medical Marketing and Media
Sunday, April 14, 2024 - 1:29pm
tags:
AbbVie, Rinvoq, OTC advertising
Merck Paid $208 Million to Stop Its Drugs From Working
Motley Fool
Sunday, April 14, 2024 - 1:27pm
tags:
Merck, M&A, Abceutics, antibody-drug conjugate
Roche, Adaptimmune part ways on cell therapy research
BioPharma Dive
Sunday, April 14, 2024 - 1:26pm
tags:
Roche, Genentech, cell therapy, cancer, Adaptimmune
Lady Gaga’s latest Nurtec ad is out and fans have something to say about it
Medical Marketing and Media
Sunday, April 14, 2024 - 1:25pm
tags:
Pfizer, migraines, Nurtec, celebrity endorsements

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels
Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)
Drug Channels

Latest Jobs

Pharmaceutical Sales- Associate Territory Manager- Primary Care
Washington DC, 20066
Eli Lilly and Company
Sales Representative
Nampa, ID, 83651
Bartlett Roofing
Pharmaceutical Sales Representative (PSR)
Iowa City, IA, 52246
Syneos Health, Inc
Diagnostics Hematology Specialist (Michigan)
Michigan, ND, 58259
Adaptive Biotechnologies
Professional Pharmaceutical Sales Representative
Pueblo, CO, 81001
Syneos Health, Inc
Pharmaceutical Sales- Associate Territory Manager- Primary Care
Covington, Georgia
Eli Lilly and Company
Manager, Inside Sales
Austin, TX
AbbVie
Vice President of Sales
Durham, NC
Confidential
Aesthetic Surgical Rep -Allergan Aesthetics, Richmond/Virginia Beach, VA
Richmond, VA, 23234
AbbVie, Inc
Generic Pharmaceuticals Inside Sales Representative
Cincinnati, OH, 45201
BluPax Pharma
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information